- Report
- July 2024
- 296 Pages
Global
From €2236EUR$2,450USD£1,900GBP
- Report
- September 2024
- 80 Pages
Global
From €5429EUR$5,950USD£4,613GBP
- Report
- March 2025
- 200 Pages
Global
From €2272EUR$2,490USD£1,931GBP
- Report
- February 2025
- 135 Pages
Global
From €2272EUR$2,490USD£1,931GBP
- Report
- February 2025
- 125 Pages
Global
From €2272EUR$2,490USD£1,931GBP
- Report
- August 2024
- 200 Pages
Global
From €2272EUR$2,490USD£1,931GBP
- Report
- June 2024
Global
From €4517EUR$4,950USD£3,838GBP
- Report
- May 2025
- 220 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 406 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 566 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 62 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 73 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 484 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 69 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 62 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 73 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 72 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 64 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 78 Pages
Global
From €5338EUR$5,850USD£4,536GBP
- Report
- May 2025
- 73 Pages
Global
From €5338EUR$5,850USD£4,536GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more